Relationship between inflammatory mediators in induced sputum and BODE-index in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 142s Year: 2007
Chronic cough and sputum production: a clinical COPD phenotype? Source: Eur Respir J 2012; 40: 4-6 Year: 2012
Induced sputum concentrations of mucin in patients with asthma and chronic cough Source: Eur Respir J 2007; 30: Suppl. 51, 61s Year: 2007
Cytokines concentrations in induced sputum of mild COPD patients. Correlation to clinical response to inhaled corticosteroids Source: Eur Respir J 2002; 20: Suppl. 38, 309s Year: 2002
Relationship between proteases/anti-proteases system in induced sputum and spirometry testing in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 634s Year: 2006
Markers of the inflammation in patients with chronic cough Source: Eur Respir J 2006; 28: Suppl. 50, 517s Year: 2006
Inflammatory subtypes in cough variant asthma (CVA): assessment using induced sputum Source: Annual Congress 2007 - Asthma subphenotypes Year: 2007
Change of induced sputum TNF-a and sTNF-R55,75 levels in patients with acute exacerbations of COPD Source: Annual Congress 2007 - Respiratory pathophysiology Year: 2007
Roles of bronchoscopy and noninvasive measurements of airway inflammation in evaluating chronic cough: the role of noninvasive measurements of airway inflammation Source: Annual Congress 2007 - PG23 - Managing chronic cough: guidelines and controversies (jointly organised with ACCP) Year: 2007
Inflammatory markers in sputum of patients with cough variant asthma Source: Eur Respir J 2002; 20: Suppl. 38, 584s Year: 2002
Functional, clinical evolution and cellular inflammatory pattern in induced sputum in patients with difficult-to-control asthma Source: Annual Congress 2011 - Update on monitoring airway diseases Year: 2011
Patient characteristics and triggers eliciting refractory chronic cough Source: International Congress 2018 – Management of chronic cough and respiratory muscle dysfunction Year: 2018
Changes in patients perception of dyspnoea, sputum volume and sputum purulence during treatment of chronic bronchitis exacerbations Source: Eur Respir J 2001; 18: Suppl. 33, 213s Year: 2001
Differences in clinical and inflammatory characteristics between steroid-withdrawal-induced and spontaneous exacerbations in patients with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 199s Year: 2002
Induced sputum in children with intermitent and persistent asthma: the effect to treatment Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma Year: 2007
Relationship between sputum inflammatory parameters, symptom scores and reduced quality of life in asthmatic patients Source: Eur Respir J 2003; 22: Suppl. 45, 179s Year: 2003
Value of induced sputum in the etiologic diagnosis of chronic cough Source: Eur Respir J 2002; 20: Suppl. 38, 449s Year: 2002
Markers of pulmonary injury and inflammation are elevated in the serum of patients with chronic cough Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021
Patterns of inflammation and the use of reversibility testing in smokers with airway complaints: The COOPT sputum induction study Source: Eur Respir J 2003; 22: Suppl. 45, 69s Year: 2003
Roflumilast significantly decreased inflammatory biomarkers in induced sputum in current smokers patients with severe chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD treatment and varia Year: 2012